Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.

Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
Capio Biosciences, Inc., a cancer diagnostic biotech startup, is partnering with the University of Wisconsin–Madison on research that will further develop novel technology in cancer detection. The Research Service Agreement (RSA) will support the research of …